Related Experiment Video
Updated: Jul 13, 2025

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.0K
Personalized Breast Cancer Screening
Dimitris Bertsimas1, Yu Ma1, Omid Nohadani2
1Sloan School of Management and Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA.
JCO Clinical Cancer Informatics
|October 16, 2023
Summary
Personalized cancer screenings using patient data significantly reduce diagnosis delays. This approach improves early detection compared to age-based guidelines, benefiting patient outcomes.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning
Background:
- Current cancer screening guidelines primarily use patient age, potentially leading to delayed or excessive screenings.
- Existing systems lack interoperability, hindering the integration of patient data across healthcare providers.
- Individual medical characteristics are often overlooked in standardized screening protocols.
Purpose of the Study:
- To develop a clinical support tool using claims data for enhanced physician decision-making in cancer screening.
- To create a machine learning framework for personalized, dynamic, and data-driven cancer screening recommendations.
- To address the limitations of age-centric screening by incorporating individual patient data.
Main Methods:
- Utilized claims data and medical insurance transactions with standardized coding for diagnoses, procedures, and medications.
- Developed a novel machine learning framework to generate personalized screening recommendations.
- Applied the methodology to breast cancer mammogram screening using data from 378,840 female patients.
Main Results:
- Personalized screening demonstrated a statistically significant reduction in average cancer diagnosis delay by 2-3 months across diverse risk populations.
- Individual patient benefits showed even greater improvements, with delays reduced by up to 10 months.
- The study highlights the effectiveness of data-driven approaches in optimizing screening timelines.
Conclusions:
- Integrating personal medical characteristics and machine learning into cancer screening enhances timeliness and adapts to evolving patient risks.
- The proposed methodology offers a valuable support tool for clinicians, improving screening decisions.
- Future implementation in healthcare settings can lead to more effective and personalized cancer care pathways.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer
48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K

